These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 140200)
1. Proactivator and activator levels of plasminogen in plasma as measured by caseinolysis. Kline DL; Reddy KN J Lab Clin Med; 1977 May; 89(5):1153-8. PubMed ID: 140200 [TBL] [Abstract][Full Text] [Related]
2. Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways. Colman RW; Bagdasarian A; Talamo RC; Scott CF; Seavey M; Guimaraes JA; Pierce JV; Kaplan AP J Clin Invest; 1975 Dec; 56(6):1650-62. PubMed ID: 1202089 [TBL] [Abstract][Full Text] [Related]
3. Factor XII-dependent fibrinolysis: a double function of plasma kallikrein and the occurrence of a previously undescribed factor XII- and kallikrein-dependent plasminogen proactivator. Kluft C; Trumpi-Kalshoven MM; Jie AF; Veldhuyzen-Stolk EC Thromb Haemost; 1979 Jun; 41(4):756-73. PubMed ID: 483248 [TBL] [Abstract][Full Text] [Related]
4. Factor XII-induced fibrinolysis. Diminished proactivator activity and drastic reduction of activator activity in Fletcher factor-deficient plasma gamma globulin. Espana F; Aznar J; Estelles A J Lab Clin Med; 1982 Nov; 100(5):756-70. PubMed ID: 6182261 [TBL] [Abstract][Full Text] [Related]
5. Plasminogen activator content of human tumor and adjacent normal tissue measured with fibrin and non-fibrin assays. Camiolo SM; Greco WR Cancer Res; 1986 Apr; 46(4 Pt 1):1788-94. PubMed ID: 3081257 [TBL] [Abstract][Full Text] [Related]
6. [Analysis of plasminogen activator in human plasma using the method of fibrin/celite column chromatography--with special reference to the determination of fibrin adsorbable tissue-plasminogen activator by ELISA]. Ieko M Hokkaido Igaku Zasshi; 1985 Nov; 60(6):834-47. PubMed ID: 4085966 [TBL] [Abstract][Full Text] [Related]
7. Extrinsic plasminogen activator: a new principle in fibrinolysis. Lijnen HR Behring Inst Mitt; 1983 Aug; (73):43-55. PubMed ID: 6236789 [TBL] [Abstract][Full Text] [Related]
8. Electrochemical assay of plasminogen activators in plasma using polyion-sensitive membrane electrode detection. Chang LC; Meyerhoff ME; Yang VC Anal Biochem; 1999 Dec; 276(1):8-12. PubMed ID: 10585738 [TBL] [Abstract][Full Text] [Related]
9. [Immunoradiometric determination of blood/tissue plasminogen activators in thrombophilia]. Astedt B; Fagner U Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):475-9. PubMed ID: 6083913 [TBL] [Abstract][Full Text] [Related]
10. Extrinsic plasminogen activator response to exercise after a single dose of propranolol. el-Sayed MS Med Sci Sports Exerc; 1992 Mar; 24(3):327-32. PubMed ID: 1549027 [TBL] [Abstract][Full Text] [Related]
11. The amidolytic activity of the SK-plasminogen complex is enhanced by a potentiator which is generated in the presence of vascular plasminogen activator--role of fibrin degradation products. Soria J; Soria C; Bertrand O; Dunn F; Samama M; Bachmann F Thromb Haemost; 1982 Jun; 47(3):193-6. PubMed ID: 7051407 [TBL] [Abstract][Full Text] [Related]
12. [Purification and properties of plasminogen activator from human blood plasma after sudden death]. Petrenko OA Biokhimiia; 1978 Aug; 43(8):1438-43. PubMed ID: 153771 [TBL] [Abstract][Full Text] [Related]
13. Studies on a complex mechanism for the activation of plasminogen by kaolin and by chloroform: the participation of Hageman factor and additional cofactors. Ogston D; Ogston CM; Ratnoff OD; Forbes CD J Clin Invest; 1969 Oct; 48(10):1786-801. PubMed ID: 4241814 [TBL] [Abstract][Full Text] [Related]
14. A lysine-absorbable plasminogen activator is elevated in conditions associated with increased fibrinolytic activity. Comp PC; Jacocks RM; Rubenstein C; Radcliffe R J Lab Clin Med; 1981 May; 97(5):637-45. PubMed ID: 6783711 [TBL] [Abstract][Full Text] [Related]
15. Chloroform-induced fibrinolysis. Its dependence on Hageman factor, plasma prekallikrein, and high molecular weight kininogen. Gordon EM; Ratnoff OD; Goldsmith GH J Lab Clin Med; 1980 Apr; 95(4):507-14. PubMed ID: 7359011 [TBL] [Abstract][Full Text] [Related]
16. [Tissue type plasminogen activator and its inhibition in blood of patients operated on for prostatic carcinoma]. Iwan-Zietek I; Zietek Z; Kotschy M; Rość D; Tyloch F Pol Tyg Lek; 1996 Feb; 51(6-9):91-3. PubMed ID: 8756741 [TBL] [Abstract][Full Text] [Related]
17. Fibrinolysis in normal subjects--comparison between plasminogen activator inhibitor and other components of the fibrinolytic system. Nicoloso G; Hauert J; Kruithof EK; Van Melle G; Bachmann F Thromb Haemost; 1988 Apr; 59(2):299-303. PubMed ID: 3133812 [TBL] [Abstract][Full Text] [Related]
18. [The properties of plasminogen activator from human blood plasma taken at sudden death]. Markova OA Biokhimiia; 1983 Jan; 48(1):132-6. PubMed ID: 6219717 [No Abstract] [Full Text] [Related]
19. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus. Glas-Greenwalt P; Kant KS; Allen C; Pollak VE J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000 [TBL] [Abstract][Full Text] [Related]
20. [Characteristics of human plasminogen activator and of a fraction of fibrinolytically active plasma enriched with this enzyme]. Plastonova TK; Petrenko OA Vopr Med Khim; 1979; 25(3):302-7. PubMed ID: 156462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]